Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right on, brother...
I gave up on trying to predict this stuff a while ago...
The potential is obviously there.
I just saw that, too.
That's a good sign.
That would make a lot of people extremely happy.
That's still a possibility. Things have been kinda crazy today...
Definitely hope so...
I saw that, too...hilarious!
I agree. Let's see what happens.
We're back on the most active list...
Always a good thing...
This could get exciting...
Any of those options would be awesome!
I agree...
There sure are a lot of pieces to this crazy puzzle...
I just think it's great that we now have an administration that actually wants to do something...anything at all.
Go MSTF!
You have nothing to apologize for -- this is a constantly changing drama and we're all learning new stuff daily.
Right on.
I like those odds...
They've got a message up now that says "Maintenance Update Alert!" Sounds like a complete overhaul. Should be interesting to see what happens...
You are definitely not alone, brother...
Not for long...
Could have something to do with yesterday's speech or maybe good news is coming...
Very strange spread...
Sounds like some positive changes in healthcare are coming. Could be very good for us...
Great post. Could finally be the break we've been waiting for.
Good luck to everyone...
From the Yahoo board:
Genta files for FDA special protocol assessment of new anticancer drug
Published:17-February-2009
By Datamonitor staff writer
Genta, a biopharmaceutical company, has submitted a proposal to the FDA for a randomized clinical trial of tesetaxel, an oral taxane chemotherapy compound, for special protocol assessment.
Related Articles
Tigris Pharmaceuticals files IND application for cancer drug
Cytopia concludes dose-escalation in Phase I cancer trial
Oncoscience withdraws marketing application for anticancer drug
Related Companies
Isis Pharmaceuticals, Inc.
Genta Incorporated
Suppliers to this Sector
Almac
A special protocol assessment is intended to secure agreement on the design, size and endpoints of clinical trials that are intended to form the primary basis of an efficacy claim in a new drug application. Genta also expects to seek scientific advice from the European Medicines Agency for this study to support a marketing authorization application. The company believes tesetaxel is the leading oral taxane currently in clinical development.
The proposed protocol will examine the safety and efficacy of tesetaxel in patients with advanced gastric cancer whose disease has progressed after receiving first-line chemotherapy. Further details of the study will be announced after a final agreement is secured with both regulatory agencies, the company said. The FDA has previously granted orphan drug designation to tesetaxel for the treatment of patients with advanced gastric cancer.
Tesetaxel is an orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Preclinically, tesetaxel has demonstrated substantially higher activity against cell lines that were resistant to paclitaxel and docetaxel, since acquired resistance is not mediated by the multidrug-resistant p-glycoprotein, the company said.
That was good...
Sounds like things are starting to come together...
Thanks for the encouraging words. Should start to get real interesting...
We've moved up to #5 on the most active chart...
They're probably just watching quietly but I'm sure they'll be making themselves heard if things continue to move in an upward direction.
Very impressive.
Hope you're right...
Volume has been insane and interest seems to be picking up.
Maybe it's time for them to come back into the light after their lengthy period of darkness.
This could get crazy...
Could the tide finally be turning?
Right on, brother. Best of luck to you and everyone else here.
I'm sure someone probably mentioned this already but we're the #2 most active board tonight! That should bring us a little more attention...